Literature DB >> 31484890

[Successful lung transplantation after long-term ventilator and extracorporeal membrane oxygenation support in a patient with severe bronchiolitis obliterans following allogeneic bone marrow transplantation].

Shuku Sato1, Eri Tanaka2, Takayoshi Tachibana3,4, Ryuta Fukai5, Tadashi Kamio6, Shingo Ichiba7, Masaaki Sato8, Yotaro Tamai1.   

Abstract

A 29-year-old man was diagnosed with acute myeloid leukemia at 20 years of age; he achieved a second complete remission at 22 years of age after an allogeneic unrelated bone marrow transplantation. After 14 months, he developed bronchiolitis obliterans (BO) due to chronic graft-versus-host disease. Home ventilator management was continuously performed for 3 years, but the patient required extracorporeal membrane oxygenation (ECMO) after progression to type 2 respiratory failure. A matched brain-dead lung donor was found after 5 months of intensive care management on ECMO, and bilateral lung transplantation was successfully performed. BO is a progressive refractory respiratory disease with poor prognosis. Careful management of infection, monitoring organ function, and lung transplantation at the appropriate time of initiation of mechanical ventilation or ECMO may save a patient's life. However, it is crucial to collaborate with higher education institutions or medical professionals in other departments.

Entities:  

Keywords:  Bronchiolitis obliterans; Extracorporeal membrane oxygenation; Home ventilator management; Lung transplantation

Mesh:

Year:  2019        PMID: 31484890     DOI: 10.11406/rinketsu.60.920

Source DB:  PubMed          Journal:  Rinsho Ketsueki        ISSN: 0485-1439


  1 in total

1.  A case of severe respiratory failure due to interstitial pneumonia successfully bridged to lung transplantation from a brain-dead donor using 109-day veno-arterial extracorporeal membrane oxygenation.

Authors:  Tokuji Ikeda; Shingo Ichiba; Takashi Sasaki; Masaaki Sato; Chihiro Konoeda; Tsukasa Okamoto; Yasunari Miyazaki; Jun Nakajima; Atsuhiro Sakamoto
Journal:  J Artif Organs       Date:  2022-06-22       Impact factor: 1.731

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.